RANITIDINE EURO

• Active substance: Ranitidine 150 mg, 300 mg

  Medicinal form: Film-coated tablets.

  Indications for use:
  Peptic ulcer of the stomach and duodenum, not associated with Helicobacter pylori (in the acute phase), including ulcer associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs);
  functional dyspepsia;
  chronic gastritis with increased acid-forming function of the stomach in the acute stage;
  gastroesophageal reflux disease (to relieve symptoms) or reflux esophagitis.

  Registration certificate: UA/4335/01/01